A review on SLE and malignancy
MY Choi, K Flood, S Bernatsky… - Best practice & research …, 2017 - Elsevier
Systemic lupus erythematosus (SLE) is a chronic, systemic autoimmune disease
characterized by autoantibody production, complement activation, and immune complex …
characterized by autoantibody production, complement activation, and immune complex …
Malignancies in systemic lupus erythematosus: a 2015 update
GC Goobie, S Bernatsky… - Current opinion in …, 2015 - journals.lww.com
Recent data confirm previously reported altered malignancy rates in SLE. Most striking in
recent years are publications further elucidating mechanisms underlying cancer …
recent years are publications further elucidating mechanisms underlying cancer …
DNA-damaging autoantibodies and cancer: the lupus butterfly theory
PW Noble, S Bernatsky, AE Clarke… - Nature Reviews …, 2016 - nature.com
Autoantibodies reactive against host DNA are detectable in the circulation of most people
with systemic lupus erythematosus (SLE). The long-held view that antibodies cannot …
with systemic lupus erythematosus (SLE). The long-held view that antibodies cannot …
Cancer and systemic lupus erythematosus
A Ladouceur, B Tessier-Cloutier… - Rheumatic …, 2020 - rheumatic.theclinics.com
Over the last 2 decades, there has been an increasing interest in links between autoimmune
disorders such as systemic lupus erythematosus (SLE) and cancer risk. The most recent …
disorders such as systemic lupus erythematosus (SLE) and cancer risk. The most recent …
[HTML][HTML] Risk of cancer in connective tissue diseases in Northeastern Italy over 15 years
E Treppo, F Toffolutti, V Manfrè, M Taborelli… - Journal of clinical …, 2022 - mdpi.com
Objective: To evaluate cancer risk among individuals with connective tissue disease (CTD)
in Friuli Venezia Giulia, northern Italy. Methods: A population-based cohort study was …
in Friuli Venezia Giulia, northern Italy. Methods: A population-based cohort study was …
Increased cancer risk in patients with cutaneous lupus erythematosus and systemic lupus erythematosus compared with the general population: A Danish nationwide …
R Westermann, K Zobbe, R Cordtz, JH Haugaard… - Lupus, 2021 - journals.sagepub.com
Objectives To investigate if patients with cutaneous lupus erythematosus (CLE) or systemic
lupus erythematosus (SLE) have an increased risk of cancer compared with the general …
lupus erythematosus (SLE) have an increased risk of cancer compared with the general …
The evolving concept of SLE comorbidities
LA González, GS Alarcon - Expert review of clinical immunology, 2017 - Taylor & Francis
Introduction: The survival of SLE patients has improved significantly over the past few
decades placing them at increased risk of cardiovascular disease (CVD), malignancies, and …
decades placing them at increased risk of cardiovascular disease (CVD), malignancies, and …
[HTML][HTML] Malignancy dominated with rheumatic manifestations: a retrospective single-center analysis
J Wen, H Ouyang, R Yang, L Bo, Y Zhang, M Tang… - Scientific Reports, 2018 - nature.com
Paraneoplastic rheumatic syndromes comprise a heterogeneous group of disorders
characterized by typical rheumatic manifestations but without direct invasion by the tumor or …
characterized by typical rheumatic manifestations but without direct invasion by the tumor or …
Systemic lupus erythematosus and malignancies: a review article
B Tessier-Cloutier, AE Clarke… - Rheumatic …, 2014 - rheumatic.theclinics.com
Systemic lupus erythematosus (SLE), an autoimmune disorder with complex environmental
and genetic interactions, affects approximately 1 in 1000 women in North America. 1 In the …
and genetic interactions, affects approximately 1 in 1000 women in North America. 1 In the …
Breast cancer in systemic lupus
S Bernatsky, R Ramsey-Goldman, M Petri… - Lupus, 2017 - journals.sagepub.com
Objective There is a decreased breast cancer risk in systemic lupus erythematosus (SLE)
versus the general population. We assessed a large sample of SLE patients, evaluating …
versus the general population. We assessed a large sample of SLE patients, evaluating …